Heartseed and novo nordisk announce first patient dosed in clinical study with hs-001 – a cell therapy designed to restore heart function in people with advanced heart failure

Hs-001 consist s of clusters of purified heart muscle cells derived from induced pluripotent stem cells (ipscs) .

NVO Ratings Summary

NVO Quant Ranking